Each round, scored, white tablet, identified by “MYSOLINE 250” contains 250 mg of primidone, USP, in bottles of 100 (NDC 66490-691-10).
Also available in a unit-dose package of 100 (NDC 66490- 691-81).
Each square-shaped, scored, white tablet, identified by “MYSOLINE 50” and an embossed M, contains 50 mg of primidone, USP, in bottles of 100 (NDC 66490-690-10) and 500 (NDC 66490-690-50).
The appearance of the 50 mg tablets is a trademark of Valeant Pharmaceuticals North America.
Store at 20°C-25°C (68°F-77°F). [See USP controlled room temperature].
Dispense in a well-closed container with a child-resistant closure.
250 mg tablet manufactured by:
Watson Laboratories, Inc.
Corona, CA 92880 USA
50 mg tablet manufactured by:
Astellas Pharma Technologies Inc.
Norman, OK 73072 USA
Valeant Pharmaceuticals N.A.
Aliso Viejo, CA 92656 USA